Document is current
Any future updates will be listed below
-
Authors
Chen, Courtney
Cillis, Jennifer
Deshpande, Supriya
Park, Anthony K.
Valencia, Hannah
Kim, Sang In
Lu, Jianming
Vashi, Yoya
Yang, Annie
Zhang, Zhifang
Woo, Yanghee
Fong, Yuman
Chaurasiya, Shyambabu
-
Funding
Funding for this research was provided by:
City of Hope
- License Information
-
More Information
Article History
Accepted: 27 August 2025
First Online: 24 September 2025
Declarations
:
: pen access funding provided by SCELC, Statewide California Electronic Library Consortium. The authors did not receive specific funding for the preparation of this article.
: Yuman Fong is a paid scientific consultant for Medtronic, Johnson & Johnson, and Imugene; receives royalties for inventions from Merck and Imugene; owns the patent for CF33-OVs and CF33-CD19t, both licensed to Imugene LTD. Yanghee Woo is a member of the scientific advisory board of Imugene LTD and J&J Ethicon. Anthony Park and Shyambabu Chaurasiya own the patent for CF33-CD19t, licensed to Imugene LTD. Courtney Chen, Jennifer Cillis, Supriya Deshpande, Hannah Valencia, Sang In Kim, Jianming Lu, Yoya Vashi, Annie Yang, and Zhifang Zhang declare that they have no conflicts of interest that might be relevant to the contents of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors read and approved the final version. Conceptualization: SC, YF, and CC. Investigation, writing—original draft, and writing—review and editing, data curation: CC, JC, SD, and SC. Writing—review and editing: CC, JC, SD, AKP, HV, SIK, JL, YV, AY, ZZ, YW, YF, and SC.
